Osteoporosis Trial, Recruiting (NCT07333989)

Osteoporosis Trial, Recruiting NCT07333989 Sponsor: Mohamed Said Alsafy Alhamrawy Condition: Osteoporosis

Printed from Voxsanity (voxsanity.com.au) — NCT07333989 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoporosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with osteoporosis, confirmed by a bone density scan (DEXA scan) showing a T-score of -2.5 or lower
People between the ages of 65 and 75 years old
People with a body mass index (BMI) between 25 and 29.9 (considered in the overweight range)
People who are mentally alert and have good cognitive (thinking and memory) function

Who may not be able to join:

People who have hormone or gland-related conditions that can affect bone health, such as early menopause, underactive sex glands, untreated overactive thyroid, overactive parathyroid glands, adrenal gland insufficiency, or Cushing's syndrome
People who currently have an active, contagious skin condition
People who have an implanted medical device, such as a pacemaker or electrical prosthesis
People who have a heart or lung condition of any kind
People who have a condition affecting the nerves or muscles
People who currently have an active viral infection
People who have a build-up of fluid in the abdomen (ascites), or end-stage liver or kidney failure
People who have a significant difference in leg length

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 23 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +201013132649

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07333989

Sponsor: Mohamed Said Alsafy Alhamrawy

Phase: Not Applicable

Status: Recruiting

Condition: Osteoporosis

Trial contact: +201013132649

More information: https://clinicaltrials.gov/study/NCT07333989

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with osteoporosis, confirmed by a bone density scan (DEXA scan) showing a T-score of -2.5 or lower
People between the ages of 65 and 75 years old
People with a body mass index (BMI) between 25 and 29.9 (considered in the overweight range)
People who are mentally alert and have good cognitive (thinking and memory) function

Who may not be able to join:

People who have hormone or gland-related conditions that can affect bone health, such as early menopause, underactive sex glands, untreated overactive thyroid, overactive parathyroid glands, adrenal gland insufficiency, or Cushing's syndrome
People who currently have an active, contagious skin condition
People who have an implanted medical device, such as a pacemaker or electrical prosthesis
People who have a heart or lung condition of any kind
People who have a condition affecting the nerves or muscles
People who currently have an active viral infection
People who have a build-up of fluid in the abdomen (ascites), or end-stage liver or kidney failure
People who have a significant difference in leg length

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 23 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Mohamed Said Alsafy Alhamrawy

Registry

ClinicalTrials.gov

Start date

2 January 2026

Est. completion

5 April 2026

Where this trial is recruiting

🇪🇬 Egypt

Primary endpoints

Balance

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov